Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-09 · accession 0001860010-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-09 | KRYS | ORTH ANDREW C. | Chief Commercial Off | M - OptEx | $63.55 | +12.5K | 12.6K | +12,500% | +$794.4K |
| DM | 2023-06-09 | 2023-06-09 | KRYS | ORTH ANDREW C. | Chief Commercial Off | S - Sale+OE | $128.61 | -12.5K | 7,339 | -63% | -$1.61M |
| D | 2023-06-09 | 2023-06-09 | KRYS | ORTH ANDREW C. | Chief Commercial Off | M - OptEx | $0.00 | -12.5K | 37.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | M | A | 12,500 | $63.55 | 12,600 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-09 | S | D | 6,906 | $128.94 | 433 | D | — | — | (F3) The transaction was executed in multiple trades ranging from $128.5600 to $129.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 3 | Common | Common Stock | 2023-06-09 | S | D | 333 | $129.70 | 100 | D | — | — | (F4) The transaction was executed in multiple trades ranging from $129.5600 to $129.7400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 4 | Common | Common Stock | 2023-06-09 | S | D | 5,261 | $128.10 | 7,339 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $127.5500 to $128.5400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-06-09 | M | D | 12,500 | $0.00 | 37,500 | D | $63.55 · — to 2032-02-27 | 12,500 Common Stock | (F5) 50,000 options were granted that vest in four equal annual installments beginning on February 28, 2023. |